FDA-Cleared AI Reads Your Routine ECG and Flags Hidden Heart Failure Before You Have ...

FDA clears EchoNext, an AI tool that detects six structural heart conditions from routine ECGs with 77% accuracy—outperforming cardiologists at 64%. The tool addresses a critical gap in early cardiovascular disease screening, particularly in settings where specialist access and echocardiography are limited.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.